New hair loss drug combo enters human trials
Disease control
Not yet recruiting
This early-stage study tests two forms of a hair loss drug (AD-303A topical and AD-3031 oral) in 30 men aged 19-55 with male pattern baldness. The goal is to see how the drug moves through the body, how well it works, and if it is safe. The study will help decide the right dose f…
Phase: PHASE1, PHASE2 • Sponsor: Moogene Medi Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC